The MarketWatch News Department was not involved in the creation of this content. New patent-pending technology helps creators reduce risk and make smarter creative decisions before content goes live.

Deployment addresses the $1 billion antibody-reproducibility crisis by enabling rapid, objective validation of research reagents, reducing wasted time and cost in research and drug development.

Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces the official launch of the ...

GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global lentivirus CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development ...

Packers fans noticed Jordan Love's stellar play during Toyota's annual sales event, leading to a clever "carspiracy" theory that Toyota embraced with special trading cards. Toyota is recalling 127,000 ...

Today we take the next step to unify your favorite AI capabilities into a single experience we call Microsoft Copilot, your everyday AI companion. Copilot will uniquely incorporate the context and ...

Lucas is a writer and narrative designer from Argentina with over 15 years of experience writing for games and news. He keeps a watchful eye at the gaming world and loves to write about the hottest ...

Over the last 40 years, Perini Ranch Steakhouse has catered numerous events, but few more memorable than that of September 11th, 2001. In this special episode, Tom and Lisa Perini share their unique ...

Toyota Motor Corp. engages in the manufacture and sale of motor vehicles and parts. It operates through the following segments: Automotive, Financial Services, and All Other. The Automotive segment ...

Toyota Motor Corp. engages in the manufacture and sale of motor vehicles and parts. It operates through the following segments: Automotive, Financial Services, and All Other. The Automotive segment ...